• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2300134 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(1) Supplementary Application 2023-07-16 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CYSB2101091 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products Supplementary Application 2021-06-15 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CXSL2200182 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(2.2) New Drug Application 2022-04-20 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CYSB2300132 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(1) Supplementary Application 2023-07-16 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CYSB2101089 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products Supplementary Application 2021-06-15 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CXSL2200180 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(2.2) New Drug Application 2022-04-20 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CYSB2300131 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(1) Supplementary Application 2023-07-16 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CXSL2200181 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(2.2) New Drug Application 2022-04-20 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CYSB2300103 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(1) Supplementary Application 2023-05-27 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CYSB2101090 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products Supplementary Application 2021-06-15 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CYSB2300104 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(1) Supplementary Application 2023-05-27 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CYSB2300133 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(1) Supplementary Application 2023-07-16 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CYSB2200077 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(1) Supplementary Application 2022-03-17 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CYSB2300102 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(1) Supplementary Application 2023-05-27 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CXSS1800021 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(1) New Drug Application 2018-09-10 安徽智飞龙科马生物制药有限公司 Anhui Zhifei Longcom Biopharmaceutical Co Ltd Certificate Issued 2020-04-27 view
CXSS1800020 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(1) New Drug Application 2018-09-10 安徽智飞龙科马生物制药有限公司 Anhui Zhifei Longcom Biopharmaceutical Co Ltd Certificate Issued 2020-04-27 view
CXSS1800022 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(1) New Drug Application 2018-09-10 安徽智飞龙科马生物制药有限公司 Anhui Zhifei Longcom Biopharmaceutical Co Ltd Certificate Issued 2020-04-27 view
CYSB2100061 重组结核杆菌融合蛋白(EC) Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) Other Biological Products(1) Supplementary Application 2021-02-26 安徽智飞龙科马生物制药有限公司 Anhui Zhifei Longcom Biopharmaceutical Co Ltd In Review 2021-02-25 view